Canada markets open in 7 hours 40 minutes

Lexaria Bioscience Corp. (LEXX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.6200-0.1400 (-5.07%)
At close: 04:00PM EDT
2.7500 +0.13 (+4.96%)
After hours: 07:33PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close2.7600
Open2.7050
Bid2.5800 x 100
Ask2.7200 x 100
Day's Range2.5500 - 2.7100
52 Week Range0.7050 - 6.8500
Volume123,286
Avg. Volume230,079
Market Cap37.527M
Beta (5Y Monthly)1.02
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • ACCESSWIRE

    Lexaria Awards CRO Contract for 12-Week DehydraTECH GLP-1 Chronic Human Study

    Weight Loss and Blood Sugar Reduction are Major Efficacy Objectives KELOWNA, BC / ACCESSWIRE / June 18, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX,)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces ...

  • ACCESSWIRE

    Dosing Continues in Lexaria’s Second GLP-1 Human Pilot Study

    Second study arm dosing is now complete. KELOWNA, BC / ACCESSWIRE / June 5, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that human pilot study #2, ...

  • ACCESSWIRE

    Lexaria Awards Contract For Third GLP-1 Human Pilot Study

    First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral format KELOWNA, BC / ACCESSWIRE / May 23, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in ...